Detail akcie Cormay PZ online

Business Summary: PZ Cormay SA is a Polish-based producer and wholesaler of diagnostic reagents and a distributor of the laboratory equipment. The Company is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. It offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, PZ Cormay SA revenues decreased 4% to PLN82.2M. Net loss decreased 35% to PLN4.5M. Revenues reflect Other segment decrease of 9% to PLN30.9M, Bangladesh segment decrease of 36% to PLN3.8M. Lower net loss reflects Foreign Exchange Loss decrease of 79% to PLN718K (expense), Selling Costs decrease of 5% to PLN24.3M (expense).